Koch's postulates, microbial dysbiosis and inflammatory bowel disease

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Symptomatic cytomegalovirus gastrointestinal infection with positive quantitative real- time PCR findings in apparently immunocompetent patients: a case.
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,
Detection of fungal DNA in lysis–centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients  L. Trovato, P. Betta, M.G.
C.N. van Ettekoven, D. van de Beek, M.C. Brouwer 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Refugee crisis and re-emergence of forgotten infections in Europe
Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance—a retrospective population based study.
Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children  N. Agrinier, M. Le Maréchal,
R. Cantón  Clinical Microbiology and Infection 
A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Non-antibiotic strategies for sepsis
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia  M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,
Vector control: a cornerstone in the malaria elimination campaign
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Isospora belli Clinical Microbiology and Infection
B. Gordts  Clinical Microbiology and Infection 
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product  T.G. Bromage  Clinical Microbiology.
Metagenomics and probiotics
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Effect of antioxidants on the immune response of Helicobacter pylori
Previously unknown species of Aspergillus
T.M. File  Clinical Microbiology and Infection 
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Abstracts cont. Clinical Microbiology and Infection
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Y. Huang, B. Yang, W. Li  Clinical Microbiology and Infection 
Antimicrobial drug development – the past, the present, and the future
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Virology: a scientific discipline facing new challenges
A. Ramette, J.M. Tiedje, A. Boetius 
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Koch's postulates, microbial dysbiosis and inflammatory bowel disease V.P. Singh, S.D. Proctor, B.P. Willing  Clinical Microbiology and Infection  Volume 22, Issue 7, Pages 594-599 (July 2016) DOI: 10.1016/j.cmi.2016.04.018 Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Koch's postulates for microbial dysbiosis and inflammatory bowel disease. We propose that the Koch's postulates can be fulfilled with some modifications to the criteria. First is the need to expand the definition from the presence of single organism in all cases to the presence of several possible pathobionts or dysbiosis in all patients. A modification of Koch's second postulate requires acceptance of molecular microbial characterization of dysbiosis in place of the isolation of the organism. Koch's third postulate also needs to allow for the introduction of several possible single organisms or a dysbiotic community. Finally, while reisolation of inoculated pathobiont from newly infected patients is possible in some cases, others require recharacterization of the dysbiotic community by molecular methods. Clinical Microbiology and Infection 2016 22, 594-599DOI: (10.1016/j.cmi.2016.04.018) Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions